Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model

Annals of Surgical Oncology

Volumn 19, Issue 12, 2012, Pages 3879-3887

  Heath, C Hope ^a   Deep, Nicholas L ^a   Sweeny, Larissa ^a   Zinn, Kurt R ^b   Rosenthal, Eben L ^a  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; IMMUNOGLOBULIN G; IRDYE800CW; MONOCLONAL ANTIBODY; PANITUMUMAB; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; DIAGNOSTIC IMAGING; DRUG TARGETING; FLUORESCENCE IMAGING; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; LYMPH NODE METASTASIS; MICROMETASTASIS; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; TUMOR BIOPSY; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; INDOLES; LYMPHATIC METASTASIS; MICE; MICE, SCID; MICROSCOPY, FLUORESCENCE; MODELS, ANATOMIC; OPTICAL IMAGING; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPECTROSCOPY, NEAR-INFRARED; SURGERY, COMPUTER-ASSISTED; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84868129909     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2435-y     Document Type: Article

References (21)

1. Spaulding DC, Spaulding BO. Epidermal growth factor receptor expression and measurement in solid tumors. Semin Oncol. 2002; 29:45-54. (Pubitemid 35191046)
2. Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, et al. (2011) Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies. J Nucl Med. 52:1778-85.
3. Themelis G, Yoo JS, Soh KS, et al. Real-time intraoperative fluorescence imaging system using light-absorption correction. J Biomed Opt. 2009;14:064012.
4. Keereweer S, Kerrebijn JD, van Driel PB, et al. Optical image-guided surgery-where do we stand? Mol Imaging Biol. 2011;13: 199-207.
5. Keereweer S, Kerrebijn JD, Mol IM, et al. Optical imaging of oral squamous cell carcinoma and cervical lymph node metastasis. Head Neck. 2011. doi:10.1002/hed.21861.
6. Biosciences L-C. 2007IRDye(R) 800CW protein labeling kit-high MW. Lincoln, NE: Li-Cor Biosciences; 2007. p. 1-9.
7. Reuthebuch O, Haussler A, Genoni M, et al. Novadaq SPY: intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest. 2004;125:418-24. (Pubitemid 38223617)
8. Gleysteen JP, Newman JR, Chhieng D, et al. Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model. Head Neck. 2008; 30:782-9. (Pubitemid 351913856)
9. van Dam GM, Themelis G, Crane LM, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011; 17:1315-9.
10. Pleijhuis RG, Graafland M, de Vries J, et al. Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol. 2009;16:2717-30.
11. Rosenthal EL, Kulbersh BD, Duncan RD, et al. In vivo detection of head and neck cancer orthotopic xenografts by immuno-fluorescence. Laryngoscope. 2006;116:1636-41. (Pubitemid 44368086)
12. Gleysteen JP, Duncan RD, Magnuson JS, et al. Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment. Cancer Biol Ther. 2007;6:1181-5. (Pubitemid 351590369)
13. Kulbersh BD, Duncan RD, Magnuson JS, et al. Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts. Arch Otolaryngol Head Neck Surg. 2007;133:511-5. (Pubitemid 46799790)
14. Marshall MV, Draney D, Sevick-Muraca EM, Olive DM. Singledose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol. 2010;12:583-94.
15. Adams KE, Ke S, Kwon S, et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt. 2007;12:024017.
16. Pomerantz RG, Grandis JR. The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol. 2004;31:734-43. (Pubitemid 39602679)
17. Withrow KP, Gleysteen JP, Safavy A, et al. Assessment of indocyanine green-labeled cetuximab to detect xenografted head and neck cancer cell lines. Otolaryngol Head Neck Surg. 2007; 137:729-34. (Pubitemid 47632926)
18. Remsen KA, Lucente FE, Biller HF. Reliability of frozen section diagnosis in head and neck neoplasms. Laryngoscope. 1984;94: 519-24. (Pubitemid 14129638)
19. Gandour-Edwards RF, Donald PJ, Lie JT. Clinical utility of intraoperative frozen section diagnosis in head and neck surgery: a quality assurance perspective. Head Neck. 1993;15:373-6. (Pubitemid 23239836)
20. Keereweer S, Sterenborg HJ, Kerrebijn JD, et al. Image-guided surgery in head and neck cancer: current practice and future directions of optical imaging. Head Neck. 2012;34:120-6.
21. Zijlstra A, Mellor R, Panzarella G, et al. A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction. Cancer Res. 2002; 62:7083-92. (Pubitemid 35424104)